Introduction
============

*Legionella pneumophila* is an accidental respiratory pathogen that can cause pneumonia in people whose immune defenses are compromised. The natural hosts of *L. pneumophila* are different species of protozoa that are abundant in aquatic environments (Lau and Ashbolt, [@B57]). *L. pneumophila* thrives in natural ecosystems such as ponds, rivers and moist soil, and also in man-made water systems, including cooling towers, whirlpools, and vegetable misters. Although protozoa routinely ingest bacteria as a food source, they can be parasitized by some species of *Legionella*. Evolutionary pressure to survive and replicate in professional phagocytes of water and soil has led to the emergence of virulence traits that also equip *L. pneumophila* to proliferate in a similar eukaryotic host, the macrophage. Protozoa and macrophages possess similar anti-microbial defenses, such as production of reactive oxygen and nitrogen species and delivery of invading microbes to the acidic, hydrolytic lysosomes via phagocytosis. Indeed, prior growth in ameba augments subsequent replication in both macrophages and mouse models of infection (Cirillo et al., [@B24], [@B23]; Neumeister et al., [@B73]).

Upon inhalation within contaminated aerosols, *L. pneumophila* are phagocytosed by alveolar macrophages. However, the nascent *L. pneumophila* phagosome avoids the endocytic pathway and instead forms a unique replication vacuole that interacts with particular organelles, including mitochondria and endoplasmic reticulum (ER; Horwitz, [@B44], [@B45]; Swanson and Isberg, [@B88]). After a few rounds of replication in permissive A/J mouse macrophages, the *L. pneumophila* vacuole acquires lysosomal components, and the progeny continue to replicate in a phagolysosomal compartment (Sturgill-Koszycki and Swanson, [@B86]). Its mode of entry and replication in host cells require a Type IV secretion system named *d*efect in *o*rganelle *t*rafficking/*i*ntra*c*ellular *m*ultiplication (Dot/Icm; Hilbi et al., [@B43]; Bandyopadhyay et al., [@B11], [@B10]; Hubber and Roy, [@B47]). To establish a replication niche, intracellular *L. pneumophila* exploit Type IV secretion to deliver to the host cytosol a large number of effectors predicted to modulate cellular pathways that are highly conserved in ameba and macrophages (Ensminger and Isberg, [@B34]). Here we focus on interactions between *L. pneumophila* and the autophagy pathway, an alternate route to the lysosomes of macrophages and amebae.

Autophagy is best known as a catabolic process in which cellular cytoplasm and organelles are degraded as a means to cope with starvation. More than 30 autophagy (Atg) genes in yeast and at least 20 in mammals regulate autophagosome formation and maturation (Mehrpour et al., [@B65]). Autophagy begins when a double-membraned structure called an isolation membrane, or phagophore, forms around cytoplasm or organelles destined for degradation. The phagophore expands and closes on itself to form a double-membraned vacuole, or autophagosome. In a series of tightly controlled events, the phagophore fuses with vesicles from the endocytic pathway. Maturation is complete when the autophagosome merges with lysosomal vacuoles to form an autophagolysosome, wherein contents of the vacuole are degraded. In addition to its long-established role as a non-selective response to starvation and more recent recognition as a selective mechanism for disposal of damaged organelles or misfolded proteins marked by ubiquitin (Pankiv et al., [@B75]; Kirkin et al., [@B54]; Thurston et al., [@B89]), autophagy is also recruited by the innate and adaptive immune systems (Levine et al., [@B58]).

Autophagy, an Innate Defense Mechanism Against Intracellular Pathogens
======================================================================

By capturing cytosolic invaders and delivering them to lysosomes, autophagy acts as a barrier against a variety of microbes. When *Streptococcus pyogenes*, *Salmonella enterica*, *Listeria monocytogenes*, or *Mycobacterium tuberculosis* damage or escape from their phagosomes, some of the microbes are ubiquitinated, recognized by the autophagic surveillance system and trafficked to lysosomes for degradation (Nakagawa et al., [@B72]; Perrin et al., [@B76]; Birmingham et al., [@B15]; Thurston et al., [@B89]; Yoshikawa et al., [@B100]; Zheng et al., [@B102]; Ponpuak et al., [@B77]). A recent study identified another pathway to capture cargo for autophagy: the cytoskeletal protein Septin traps *Shigella flexneri* within a meshwork that targets the intracellular bacterium for autophagic degradation (Mostowy et al., [@B68]).

Bacterial pathogens that reside in endosomal compartments also face death by autophagy, and some of the host regulatory factors have been identified. For example, IFN-γ stimulated cells deliver vacuoles containing *M. tuberculosis* to lysosomes via autophagy (Gutierrez et al., [@B39]). Similarly, *Chlamydia trachomatis* inclusion vacuoles, which typically evade lysosomes, are routed to the autophagic pathway upon IFN-γ activation. This alteration in trafficking is mediated by the host immunity related GTPase (IRG), Irga6 (Al-Younes et al., [@B2]; Al-Zeer et al., [@B3]). Infection by the parasite *Toxoplasma gondii* is also controlled by autophagy *in vivo* and *in vitro*. CD40 signaling recruits the autophagy pathway to capture the intracellular parasites, evident from the exacerbated ocular and brain pathology displayed by CD40−/− mice, which are susceptible to chronic toxoplasmosis (Andrade et al., [@B6]; Ling et al., [@B59]). *S. enterica* serovar Typhimurium is captured within autophagosomal membranes derived from the ER by a mechanism that requires Rab1 (Huang et al., [@B46]), a host GTPase that will be discussed in more detail below.

Selective pressure to circumvent autophagic killing has led to emergence of virulence traits that equip pathogens to survive and replicate in host cells. *Coxiella burnetii* is an intracellular pathogen that proliferates in spacious vacuoles that eventually fuse with lysosomes. For efficient replication, *C. burnetii* requires induction of autophagy and inhibition of apoptotic cell death (Beron et al., [@B14]; Gutierrez et al., [@B40]; Romano et al., [@B83]). *Francisella tularensis* has a remarkable trafficking pattern inside mouse bone marrow-derived macrophages. Soon after infection, *F. tularensis* breaks out of its phagosome and replicates in the cytoplasm. At later stages of infection, *F. tularensis* resides in vacuoles with features of autophagosomes. After reentering the endocytic pathway via autophagy, *F. tularensis* can be exocytosed from the cell (Checroun et al., [@B21]).

Several lines of evidence have also pointed to autophagy as a strategy for host cells to combat *L. pneumophila* infection. First, *Dictyostelium discoideum* that lack the autophagy protein Atg9 are more permissive for infection by *L. pneumophila* (Tung et al., [@B92]). Likewise, when expression of Atg5 by A/J mouse peritoneal macrophages is reduced by siRNA, the yield of *L. pneumophila* increases throughout the 48-h infection period (Matsuda et al., [@B64]). Conversely, *L. pneumophila* replication is inhibited when autophagy is induced by treating A/J macrophages with 2-deoxy-d-glucose (Matsuda et al., [@B64]), a non-hydrolyzable analog of glucose that inhibits glycolysis (Wick et al., [@B95]). In addition, as discussed in more detail below, the *L. pneumophila* vacuole traffics along the autophagic pathway more rapidly in restrictive C57Bl/6 mouse macrophages compared with permissive A/J *naip5* mutant mouse macrophages (Amer and Swanson, [@B5]). Next we review morphological, molecular, and immunological data, drawn primarily from studies of *L. pneumophila* trafficking in A/J mouse macrophages, that are consistent with a model in which *L. pneumophila* utilizes effectors of the Dot/Icm Type IV secretion system to stall progression of its autophagosomal vacuole to overcome this innate defense against intracellular infection.

ER Contributes to Biogenesis of *L. pneumophila* Vacuoles and Autophagosomes
============================================================================

The biogenesis of the *L. pneumophila* replication vacuole is remarkably similar to autophagosome formation. First, the two vacuoles can receive membrane from the same source, the ER. Elegant electron microscopic studies first by Horwitz and later by Swanson and Tilney and their colleagues describe *L. pneumophila* vacuole biogenesis (Horwitz, [@B45]; Swanson and Isberg, [@B88]; Tilney et al., [@B90]). Immediately after infection, the *L. pneumophila* phagosomal membrane resembles the host plasma membrane. Within minutes of uptake by U937 human monocytic cells, osmophilic hair-like projections connect vesicles to the cytoplasmic face of the *L. pneumophila* phagosome. These vesicles appear to fuse with the phagosomal membrane and with each other to form a double-membraned vacuole, whose thickness is typical of ER. Within the first hours of infection, ribosomes are attached to the cytoplasmic face of the vacuole, which now resembles rough ER. Furthermore, fluorescence microscopy studies of macrophages derived from bone marrow of A/J mice demonstrate that *L. pneumophila* vacuoles co-localize with a variety of ER markers, including the luminal proteins BiP, glucose-6-phosphatase, and protein disulfide isomerase; the ER membrane proteins calnexin and Sec22b; and yellow fluorescent protein coupled to the ER localization signal KDEL (Swanson and Isberg, [@B88]; Kagan and Roy, [@B51]; Derre and Isberg, [@B29]; Robinson and Roy, [@B82]; Arasaki and Roy, [@B7]).

Several recent reports provide compelling morphological evidence that the ER is also one source of autophagosomal membranes (Axe et al., [@B9]; Hayashi-Nishino et al., [@B42]; Yla-Anttila et al., [@B99]). Autophagosomes originate at phosphatidylinositol-3-phosphate (PI3P)-enriched sections of ER called omegasomes. In addition, autophagosomes are connected to the ER by narrow extensions, and their membranes are a similar thickness (5--7 nm; Arstila and Trump, [@B8]; Yla-Anttila et al., [@B99]). Furthermore, immunoelectron microscopy studies of the phagophore membranes identify ER marker proteins and cisternae (Hayashi-Nishino et al., [@B42]). Thus, in addition to the plasma membrane (Ravikumar et al., [@B79]) and mitochondria (Hailey et al., [@B41]), the ER can contribute membrane for autophagosome biogenesis.

Initiation and elongation of the phagophore is coordinated by a cascade of Atg proteins, including two ubiquitin-like conjugation systems (Geng and Klionsky, [@B38]; Mehrpour et al., [@B65]). Once Atg7 activates Atg12, then Atg5 is conjugated to Atg12. Atg16L1 is recruited to the growing autophagosome where it forms a multimeric complex with Atg5 and Atg12. Next, cytosolic Atg8, also known as LC3, is cleaved and conjugated to phosphatidylethanolamine in the autophagosomal membrane. Conjugation of LC3 to phosphatidylethanolamine depends on Atg7 and the Atg5--Atg12:Atg16L1 complex. As the phagophore closes to form an autophagosome, Atg16L1 dissociates. Like autophagosomes, newly formed *L. pneumophila* vacuoles sequentially acquire and then lose Atg7 and Atg8/LC3 (Amer and Swanson, [@B5]).

During starvation-induced autophagy, the sudden demand for membrane may be readily met by membranous folds of the ER. Similar to *L. pneumophila*, the intracellular eukaryotic parasite *T. gondii* resides in a protective vacuole that interacts intimately with the ER (Melo and de Souza, [@B66]) and that can also be a target of autophagy (Andrade et al., [@B6]; Ling et al., [@B59]). Accordingly, we propose that, in response to cytosolic infection, the autophagy machinery recruits the ER to sequester invading microbes.

*L. pneumophila* Vacuoles and Autophagosomes Merge with the Lysosomes
=====================================================================

In the initial stages of infection, the *L. pneumophila* vacuole does not fuse with lysosomes (Horwitz, [@B45]). The vacuole is isolated from the endocytic pathway, as the compartment is inaccessible to exogenous soluble and lipid probes (Joshi et al., [@B50]). Nutrient cues likely trigger differentiation of intracellular *L. pneumophila* to the replicative phase (Sauer et al., [@B84]; Wieland et al., [@B97]). Since only post-exponential phase *L. pneumophila* express the virulence factors that inhibit phagosome--lysosome fusion (Byrne and Swanson, [@B18]; Fernandez-Moreira et al., [@B36]), the differentiation state of the bacteria impacts the fate of the pathogen's vacuole. Beginning \~8 h after infection of A/J mouse macrophages, lysosomal markers co-localize with the *L. pneumophila* vacuole (Sturgill-Koszycki and Swanson, [@B86]). Although *L. pneumophila* can replicate at neutral pH in broth and human monocytic cells (Wieland et al., [@B96]), in A/J macrophages fusion with the lysosomes actually promotes bacterial replication, since pharmacological inhibition of lysosome acidification and phagosome maturation by bafilomycin A inhibits *L. pneumophila* growth. The period when lysosome fusion is stalled likely allows the bacteria to differentiate to an acid-resistant form (Sturgill-Koszycki and Swanson, [@B86]). The lysosomal bacteria continue to replicate in A/J macrophages for an additional 10--15 h, until the cell lyses to release progeny that are primed for infection (Byrne and Swanson, [@B18]).

The fate of a newly formed autophagosome is similar to that of the *L. pneumophila* replication vacuole. Once formed from membranes of the ER, autophagosomes quickly fuse with early endosomes and late endosomes, generating vacuoles referred to as amphisomes (Liou et al., [@B60]; Berg et al., [@B13]; Swanson et al., [@B87]). These vacuoles acidify and traffic along the microtubular network toward the perinuclear region, where they merge with lysosomes (Kimura et al., [@B53]).

From the origin of their membrane to their final destination, the *L. pneumophila* vacuole and the autophagosome share many morphological features. However, differences exist between the two vacuoles. First, unlike *L. pneumophila* replication vacuoles, autophagosomes do not accumulate ribosomes on their surface. Second, in macrophages derived from the bone marrow of A/J *naip5* mutant mice, non-selective autophagosomes induced by starvation or pharmacologically mature at a faster rate than *L. pneumophila* vacuoles (Amer and Swanson, [@B5]). We speculate that the capacity of particular Type IV effector proteins, discussed below, to prolong interactions with the ER slows maturation of the *L. pneumophila* autophagosomal vacuole, enabling ribosomes to accumulate.

Genetic analysis of the contribution of Atg proteins to biogenesis of *L. pneumophila* replication vacuoles is one approach to test the impact of autophagy on the pathogen's fate. Otto et al. ([@B74]) analyzed the yield of *L. pneumophila* over an 8-day period in wild-type *D. discoideum* or a number of autophagy mutants. The host factors analyzed were Atg1 and Atg6, proteins that contribute to the initial stages of autophagosome formation, and Atg5, Atg7, and Atg8, components of ubiquitin-like conjugation systems that mediate autophagosome elongation (Chen and Klionsky, [@B22]). Since the mutant ameba supported *L. pneumophila* replication to levels similar to wild-type, *L. pneumophila* can replicate independently of several factors that promote autophagosome biogenesis. Whether the bacteria resided in ER-derived. lysosomal, or other compartments when *L. pneumophila* replication was first evident \>48 h after infection of the *atg* mutant *D. discoideum* was not analyzed. Subsequent molecular genetic studies in the *D. discoideum* model reported that the autophagy protein Atg9 equips amebae to restrict infection by *L. pneumophila* (Tung et al., [@B92]). Kinetic studies using markers for ER and the endosomal pathway in wild-type and mutant *D. discoideum* phagocytes are needed to determine when the *L. pneumophila* vacuole intersects the autophagy pathway, whether the pathogen delays autophagosome maturation, and the composition of vacuoles that support bacterial replication in these environmental host cells.

A Subset of GTPases Direct ER Recruitment by Both *L. pneumophila* Vacuoles and Autophagosomes
==============================================================================================

Rab proteins are small GTP-binding proteins that regulate vesicle trafficking. Rab proteins cycle between a cytosolic, inactive GDP-bound state and a membrane-associated, active GTP-bound state (Barr and Lambright, [@B12]). Cycling between the two states is catalyzed by guanine exchange factors (GEFs), proteins that exchange GDP for GTP, and by GTPase activating proteins (GAPs) that stimulate GTP hydrolysis to inactivate the Rab protein. Additionally, Rab proteins bind SNARE and SNARE-associated proteins, soluble effector proteins that mediate membrane fusion. As vesicles progress along either the secretory and endosomal pathways, Rab proteins dedicated to each distinct compartment are sequentially recruited and then displaced: this so-called "Rab conversion" is critical for maturation of the organelles (Rink et al., [@B81]).

*Legionella pneumophila* replication vacuoles and autophagosomes each associate with Rab1, a GTPase of the early secretory pathway that regulates fusion between vesicles exiting the ER and the cis-Golgi (Stenmark, [@B85]). Immediately after uptake by A/J mouse macrophages or U937 human monocytic cells, Rab1 co-localizes with the *L. pneumophila* phagosome; by 4 h, it cycles off the vacuole (Derre and Isberg, [@B30]; Kagan et al., [@B52]). Rab1 promotes bacterial replication, since transfection of COS1 and CHO cells with an inactive form of Rab1 reduces the yield of *L. pneumophila*.

Several *L. pneumophila* effectors that regulate Rab1 activity have been identified, highlighting the significance of this host protein for *L. pneumophila* trafficking. For example, two *L. pneumophila* Type IV secreted proteins, DrrA and LidA, increase the pool of Rab1--GTP, whereas a third, LepB, stimulates GTP hydrolysis to generate Rab1--GDP (Murata et al., [@B70]; Ingmundson et al., [@B48]; Machner and Isberg, [@B63]; Brombacher et al., [@B16]; Muller et al., [@B69]). The capacity of this trio of *L. pneumophila* effectors to modulate trafficking in the host secretory pathway was verified when their ectopic expression disrupted the Golgi network of CHO and COS1 cells (Derre and Isberg, [@B31]; Machner and Isberg, [@B63]). LidA may play additional roles because it also interacts with Rab6 and Rab8, and the effector is expressed throughout the bacterial replication period (Conover et al., [@B26]; Machner and Isberg, [@B63]).

Time course studies of co-localization of the *L. pneumophila* effectors that modulate Rab1 suggest that the pathogen vacuole retains secretory vesicles for a defined period. Both DrrA and LidA are detected on *L. pneumophila* vacuoles shortly after uptake by primary mouse macrophages (Conover et al., [@B26]; Ingmundson et al., [@B48]). In contrast, LepB decorates the *L. pneumophila* vacuole at later times, reaching a high plateau 9 h after infection of A/J mouse macrophages (Ingmundson et al., [@B48]). Single cell analysis underscored that as LepB accumulates, host Rab1 and bacterial DrrA/SidM disassociate from the *L. pneumophila* vacuole, becoming undetectable by 4 h. The continued presence of DrrA and LidA during the initial stage of *L. pneumophila* vacuole maturation is predicted to ensure persistent Rab1 activation and prolong recruitment of ER vesicles. By blocking Rab conversion, retention of active Rab1 by DrrA and LidA may stall *L. pneumophila* vacuole maturation by inhibiting association of downstream Rab GTPases such as Rab5 and Rab7, which facilitate fusion with early and late endosomes, respectively. Subsequent secretion by *L. pneumophila* of the effector LepB catalyzes Rab1 to cycle to its inactive form. As a consequence, Rab conversion is predicted to proceed, thereby relieving the block to autophagosome maturation. By this stage of the infection of A/J macrophages, the intracellular bacteria have differentiated to a replicative form that is acid-resistant and equipped to exploit lysosomes as a replication niche (Sturgill-Koszycki and Swanson, [@B86]).

Consistent with the contribution of ER membrane to autophagosome biogenesis, Rab1 co-localizes with LC3 (Atg8) on autophagosomes generated by starvation of CHO cells (Zoppino et al., [@B103]). Rab1-positive autophagosomes do not acquire cathepsin D or degradative capacity, indicating that these vesicles represent an early stage of autophagosome maturation. Moreover, over-expression of Rab1 stimulates autophagosome biogenesis, as judged by localization and processing of LC3. Conversely, reducing Rab1 expression by siRNA reduces autophagy (Zoppino et al., [@B103]). Using similar approaches, Huang et al. ([@B46]) documented that Rab1 contributes to autophagosome formation, clearance of ubiquitinated protein aggregates, and sequestration and degradation of *Salmonella typhimurium*. In summary, Rab1 association with *L. pneumophila* vacuoles and with autophagosomes is a critical step in biogenesis of both of these ER-derived vacuoles. By secreting effectors that trap active Rab1, *L. pneumophila* is predicted to stall maturation, providing the time needed for the pathogen to differentiate to a state that can tolerate and exploit an acidic, hydrolytic autophagolysosomal compartment of A/J macrophages.

A second GTPase in the early secretory pathway that has been implicated in the biogenesis of both *L. pneumophila* replication vacuoles and autophagosomes is Sar1. CHO FcgRII cells that express a dominant negative form of Sar1 fail to tether ER vesicles to the *L. pneumophila* phagosome, and their bacterial yield 11 h after infection is reduced (Kagan and Roy, [@B51]). Likewise, CHO cells that express either a dominant negative form of Sar1 or reduced amounts of wild-type Sar1 protein contain fewer autophagosomes (Zoppino et al., [@B103]). That Sar1 promotes formation of *L. pneumophila* replication vacuoles and autophagosomes lends further strength to the model that *L. pneumophila* is captured by autophagy, but the pathogen utilizes Type IV secretion to stall this host defense pathway, securing time for the intracellular bacterium to adapt to its replication niche.

Arf1 is a third host GTPase known to regulate vesicular traffic in the secretory pathway that contributes to formation of not only *L. pneumophila* replication vacuoles but also autophagosomes. *L. pneumophila*-infected CHO FcgRII cells that express a dominant negative form of Arf1 contain a reduced number of intracellular bacteria 11 h after infection (Kagan and Roy, [@B51]). The *L. pneumophila* Type IV secretion effector protein RalF acts as a GEF that promotes Arf1 association with the bacterial vacuole (Nagai et al., [@B71]). However, since RalF mutants do not exhibit the intracellular growth defect observed in cells whose Arf1 function is impaired, other bacterial factors likely regulate the GTPase activity. Recent experiments in yeast determined that Arf1 also contributes to autophagosome biogenesis. In particular, genetic analysis identified this GTPase, as well as the Arf1 GEF protein Sec7, as critical for the Atg8/LC3 processing that promotes autophagosome biogenesis (van der Vaart et al., [@B93]). Thus, Arf1 is one of three GTPases that function in the secretory pathway and contribute to biogenesis of both *L. pneumophila* replication vacuoles and autophagosomes.

Polyubiquitinated Proteins are Associated with Autophagosomes and *L. pneumophila* Vacuoles
===========================================================================================

Since polyubiquitinated proteins are cargo for autophagosomes and also surround *L. pneumophila* vacuoles, they provide more clues to understanding the pathogen's fate. Ubiquitination is an evolutionarily conserved mechanism that tags proteins for degradation by host proteasomes or lysosomes (Clague and Urbe, [@B25]). Ubiquitin also targets proteins and cytosolic bacteria for selective autophagy. The cytoplasmic adaptor proteins p62, NBR1, or NDP52 bind either ubiquitinated protein aggregates or intracellular *S. typhimurium, L. monocytogenes*, or *M. tuberculosis*, marking them as cargo for selective autophagy (Pankiv et al., [@B75]; Kirkin et al., [@B54]; Thurston et al., [@B89]; Yoshikawa et al., [@B100]; Ponpuak et al., [@B77]). For example, *S. typhimurium* that enter the cytosol become ubiquitinated and are degraded by autophagy, and p62 and NDP52 are required for efficient killing of the cytosolic bacteria (Zheng et al., [@B102]).

Shortly after ingestion by A/J mouse macrophages, U937 human monocytic cells or *Acanthamoeba polyphaga*, the *L. pneumophila* vacuole is studded with ubiquitinated proteins, which persist during the bacterial replication period (Dorer et al., [@B33]; Ivanov and Roy, [@B49]; Price et al., [@B78]). A number of proteins translocated by the Dot/Icm Type IV secretion system contain F-box and U-box motifs, hallmarks of E3 ubiquitin ligases, which transfer ubiquitin to proteins to be degraded (Cazalet et al., [@B20]; Al-Khodor et al., [@B1]; Kubori et al., [@B56]). At least two of the five known F-box containing proteins of *L. pneumophila* exhibit E3 ubiquitin ligase activity and interact with host proteins (Ensminger and Isberg, [@B35]; Lomma et al., [@B61]). For example, AnkB (LegAU13) induces ubiquitinated proteins to accumulate on the bacterial vacuole; it also enhances intracellular of growth of one strain of *L. pneumophila*, but not others (Al-Khodor et al., [@B1]; Ivanov and Roy, [@B49]; Ensminger and Isberg, [@B35]). LubX is a U-box containing E3 ubiquitin ligase that negatively regulates the bacterial Dot/Icm effector SidH by ubiquitinylation and also increases survival of infected *D. melanogaster* (Kubori et al., [@B56]). However, LubX is not required for *L. pneumophila* replication inside murine macrophages or protozoan cells (Kubori et al., [@B55]). Yet, bacterial replication is attenuated in cells that express reduced amounts of the host proteins Clk1, a substrate of LubX, and Cdc48/p97, a chaperone predicted to enhance translocation of ubiquitinated Type IV secretion substrates (Dorer et al., [@B33]; Kubori et al., [@B55]).

At present it is unclear whether ubiquitination of the *L. pneumophila* vacuole is driven by the pathogen, or the host. The protein modification may aid translocation of Type IV secretion substrates, or modulate maturation of the vacuole. Certain host Atg enzymes catalyze ubiquitin-like reactions during autophagosome biogenesis. However, since none of the Atg proteins have the structure or the HECT- or RING-type motifs typical of E3 ligases (Geng and Klionsky, [@B38]), it seems unlikely that any of the known *L. pneumophila* E3 enzymes, which do contain these motifs, act directly as mimics of Atg proteins. An alternative hypothesis that remains to be tested is that, by tagging vacuoles modified or damaged by Type IV secretion with ubiquitin, the host cell directs *L. pneumophila* to the selective autophagic pathway, perhaps via the adaptor proteins NDP52 or p62 (Thurston et al., [@B89]; Ponpuak et al., [@B77]). Consistent with the idea that ubiquitination of the pathogen vacuole is advantageous to the host is the unexpected observation that the F-box bacterial effector AnkB reduces, rather than increases, endogenous ubiquitination of one host target protein (Lomma et al., [@B61]).

Maturation of the *L. pneumophila* Vacuole is Governed by the Innate Immune Response
====================================================================================

The innate intracellular immune receptor Naip5 plays a critical role in resistance to *L. pneumophila* infection (Diez et al., [@B32]; Wright et al., [@B98]; Derre and Isberg, [@B30]; Zamboni et al., [@B101]). Naip5 is a NOD-like receptor (NLR) protein postulated to detect cytosolic contamination of flagellin delivered to the cytoplasm, perhaps via the Dot/Icm system. Recognition of flagellin by Naip5 initiates host immune responses that control *L. pneumophila* infection in C57Bl6 macrophages (Amer et al., [@B4]; Molofsky et al., [@B67]; Ren et al., [@B80]; Fortier et al., [@B37]). Interestingly, in A/J macrophages, which have reduced Naip5 function, maturation of the *L. pneumophila* vacuole is sluggish, and the pathogen replicates to high numbers (Amer and Swanson, [@B5]). For example, bone marrow-derived macrophages from A/J mice display maximum co-localization of Atg7 with *L. pneumophila* phagosomes within minutes, and then the association diminishes by 2 h. LC3 becomes visible on the phagosome at 4 h; by 6 h, 50% of *L. pneumophila* phagosomes co-localize with LC3. In contrast, in restrictive C57Bl6 macrophages Atg7 and LC3 association with the bacterial vacuole is rapid: by 1 h, some phagosomes first acquire, and then shed, both Atg7 and Atg8 (Amer and Swanson, [@B5]); by 2 h more vacuoles have merged with lysosomes (Fortier et al., [@B37]); by 48 h, intracellular bacteria are degraded (Molofsky et al., [@B67]). Whether Naip5 protein equips mouse macrophages to restrict *L. pneumophila* infection by promoting a rapid autophagic response to cytosolic contamination remains to be tested directly in isogenic mouse strains. We next propose a model that incorporates these interesting mouse genetics observations in the context of the morphological and molecular genetic studies of the biogenesis of *L. pneumophila* vacuoles and autophagosomes.

*L. pneumophila* Vacuoles Resist Maturation Along Autophagic Pathway
====================================================================

We postulate that, when confronted by autophagy as a host defense, *L. pneumophila* retards autophagosome maturation to establish a productive infection in professional phagocytes. The morphological and molecular similarities between biogenesis of *L. pneumophila* replication vacuoles and autophagosomes, as well as the capacity of Naip5 to restrict infection of mouse and human macrophages by *L. pneumophila* and increase delivery of the pathogen to lysosomes (Diez et al., [@B32]; Wright et al., [@B98]; Derre and Isberg, [@B30]; Amer et al., [@B4]; Molofsky et al., [@B67]; Fortier et al., [@B37]; Vinzing et al., [@B94]) are consistent with the following working model (Figure [1](#F1){ref-type="fig"}). After uptake by cells, *L. pneumophila* effectors along with contaminating flagellin are transported by Type IV secretion to the host cytoplasm. Recognition of flagellin by Naip5 triggers the autophagic defense mechanism, which relies on the GTPases Rab1, Arf1, and Sar1 to deliver secretory vesicles from the ER to envelop the pathogen's vacuole. To inhibit rapid maturation into a toxic, acidic autophagolysosome, *L. pneumophila* immediately delivers Type IV effectors to retain ER components. In particular, DrrA and LidA secreted by the pathogen activate and retain Rab1. Likewise, the bacterial effector RalF activates Arf1. Retention of active Rab1 and Arf1 prevents their replacement by a distinct set of Rab proteins needed to recruit vesicles from the endosomal pathway. Thus, *L. pneumophila* stalls in an ER-derived vacuole that resembles an immature autophagosome. After several hours in permissive A/J macrophages, *L. pneumophila* expresses a new class of effectors, including LepB, that release Rab1 from the vacuole (Ingmundson et al., [@B48]). As a consequence, the vacuole resumes maturation to form an autophagolysosome. Presumably, a deliberate, measured pause within an ER-derived immature autophagosome provides *L. pneumophila* time sufficient to induce acid resistance and other traits critical to exploit lysosomes as a replication niche (Sturgill-Koszycki and Swanson, [@B86]). For example, *L. pneumophila* can use as a nutrient source short peptides (Sauer et al., [@B84]; Wieland et al., [@B97]), which are likely abundant in lysosomes. Thus, we speculate that residence in the lysosomal compartment provides a constant supply of nutrients and vacuolar membrane to support bacterial replication in A/J macrophages.

Our model predicts that, in response to cytosolic flagellin, the NLR protein Naip5 stimulates macrophage autophagy as a barrier to cytosolic infection. A precedent for NLR-mediated induction of autophagy is the discovery that NOD1 and NOD2 physically interact with Atg16L1 and promote autophagy of intracellular *S. flexneri* and *S. typhimurium* (Cooney et al., [@B27]; Travassos et al., [@B91]). In particular, we postulate that the wild-type level of Naip5 protein expressed by restrictive C57Bl6 macrophages triggers a robust autophagic response (Amer and Swanson, [@B5]) that is sufficient to overcome the pathogen's effector proteins and deliver the vacuole to lysosomes. In contrast, the partial Naip5 function of A/J macrophages elicits a sluggish autophagic response, and the *L. pneumophila* effectors successfully stall autophagosome maturation. Our model also predicts either that autophagosomes mature more slowly in human macrophages and amebae, which are permissive for infection, compared to mouse phagocytes, which are not. Alternatively, the bacterial effectors DrrA, LidA, and RalF may bind and activate the Rab1 and Arf1 proteins of human and amebae more efficiently than the mouse substrates. Thus, we postulate that the outcome of *L. pneumophila* infection of environmental or mammalian phagocytes is dictated by a competition: how efficiently host autophagy delivers the microbe to lysosomes versus How effectively the pathogen arsenal unleashed by Type IV secretion stalls autophagosome maturation.

![**Model for stalled maturation of the *L. pneumophila* vacuole in the autophagic pathway of permissive phagocytes**. ER serves as a membrane source for both *L. pneumophila* vacuoles and autophagosomes. Early secretory vesicles (gray circles) from the ER are recruited to both organelles in a Rab1-, Arf1-, and Sar1-dependent manner. The double-membraned, LC3 positive, autophagosome sequentially fuses with vesicles from the early endocytic pathway and finally with lysosomes, where its cargo is degraded. Maturation of *L. pneumophila* is stalled at an early stage when bacterial proteins (italics) DrrA and LidA persistently activate Rab1 and RalF activates Arf1. Thus, the vacuole acquires ER markers BiP, glucose-6-phosphate, calnexin, protein disulfide isomerase, YFP--KDEL, and ribosomes (filled circles). After several hours, *L. pneumophila* secretes LepB, an effector that inactivates Rab1, releasing it from the membrane. Subsequently, the immature autophagosomal vacuole matures to an autophagolysosome, which accumulates the lysosomal proteins cathepsin D and LAMP1. The deliberate pause coordinated by Type IV secretion effectors enables the pathogen to differentiate into an acid-resistant, replicative form that exploits lysosomes as a replication niche.](fmicb-02-00138-g001){#F1}

Conclusion
==========

A large number of effectors released by *L. pneumophila* have eukaryotic-like motifs and functions (Cazalet et al., [@B20]; Lurie-Weinberger et al., [@B62]). Remarkably, a number of these proteins equip the pathogen to modulate the activity of host GTPases, first to stall, and then later resume, the exchange of vesicles from the host secretory pathway. By this strategy, *L. pneumophila* delays its immediate delivery to anti-microbial autophagolysosomes.

Autophagy is modulated by at least two other pathogens to replicate inside cells, *C. burnetii* and *F. tularensis*. The *C. burnetii* phagosome associates with LC3 within minutes, and this association is maintained for up to 48 h in CHO cells (Gutierrez et al., [@B40]; Romano et al., [@B83]). Notably, cathepsin D, a lysosomal enzyme, is acquired at a slower rate by phagosomes containing live *C. burnetii* compared with inactivated bacteria (Romano et al., [@B83]). The authors propose that association of *C. burnetii* with autophagosomes delays their delivery with lysosomes, perhaps providing time for infectious *C. burnetii* to differentiate into their replicative cell type. Later in infection, maturation of the *C. burnetii* phagosome depends on association with Rab1 and fusion with vesicles from the early secretory pathway, possibly to acquire nutrients and membrane for the expanding vacuole (Campoy et al., [@B19]).

Similar to *L. pneumophila* and *C. burnetii*, delay in progression along the autophagic pathway has been suggested as a successful strategy of *F. tularensis*. Peripheral blood monocytes infected with *F. tularensis* down regulate key autophagy genes, as shown by microarray analysis; yet, morphological evidence demonstrates *F. tularensis* within autophagosomal vacuoles later in infection (Checroun et al., [@B21]; Butchar et al., [@B17]). Perhaps by inhibiting expression of autophagy genes, *F. tularensis* secures the time needed to differentiate to a form that can resist the harsh environment of autophagolysosomes (Cremer et al., [@B28]). Moreover, *F. tularensis* may hijack exocytosis of lysosomes to egress out of the cell. In summary, the three pathogens *L. pneumophila*, *C. burnetii*, and *F. tularensis* appear to manipulate the autophagic system to meet their particular nutritional, membrane expansion, and exit requirements. Accordingly, pharmaceutical induction of autophagy may be an effective strategy to combat infection by these and other intracellular pathogens.

Two of the outstanding questions in the autophagy field are how autophagosomes select their cargo and how their maturation is regulated. As a genetically tractable BSL2 microbe, *L. pneumophila* is an attractive tool to study autophagic processes, which remain challenging to track. Indeed, observations regarding the contribution of secretory pathway membranes and GTPases to autophagosome-like vacuoles were made first by *Legionella* experimentalists and later by the autophagy field. By exploiting *L. pneumophila* as a molecular genetic probe, scientists can gain insight to the mechanisms that regulate formation and maturation of autophagosomes.
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